Sebaoun, Perle <br/><br/>
[Tolerance of Tamoxifen as an adjuvant therapy and long-term follow up of 55 premenopausal breast cancer women, cared for at the Institut de cancérologie de Lorraine, treated with Tamoxifen].  [electronic resource] 

 -  Bulletin du cancer  Dec 2019 
 - S75-S100 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1769-6917 
<br/><br/><label>Standard No.: </label>10.1016/S0007-4551(20)30050-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Amenorrhea--chemically induced<br/>Antineoplastic Agents, Hormonal--administration & dosage<br/>Aromatase Inhibitors--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Cancer Care Facilities<br/>Chemotherapy, Adjuvant<br/>Female<br/>Follow-Up Studies<br/>France<br/>Hot Flashes--chemically induced<br/>Humans<br/>Incidence<br/>Ovarian Cysts--chemically induced<br/>Premenopause<br/>Progression-Free Survival<br/>Prospective Studies<br/>Retrospective Studies<br/>Selective Estrogen Receptor Modulators--administration & dosage<br/>Tamoxifen--administration & dosage<br/>Time Factors